| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.38 |
5e-13 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.31 |
7e-12 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.29 |
3e-10 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0001 |